No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...
Patients who have two variants in the gene will likely be much sicker, much faster. Drug authorities in the UK and European Union have recommended pre-treatment DPYD testing since 2020.